These data show the clinical importance of SEMA3F, NRP1 and NRP2 in DCIS-to-IDC BC progression and correlate with the activation of EMT in IDC versus DCIS [37]. The gene discussed is SEMA3F; the disease is ductal breast carcinoma in situ.